Application 208906

Type
ANDA
Sponsor
ACTAVIS LABS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TREPROSTINILTREPROSTINILTABLET, EXTENDED RELEASE;ORAL0.125MGNoNo
002TREPROSTINILTREPROSTINILTABLET, EXTENDED RELEASE;ORAL0.25MGNoNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
74153ORIG 2023-05-02